HEALTH CARE/PROVIDERS: Provides civil and criminal immunity for the distribution or use of Naloxone and other opioid antagonists beyond their shelf-life end date
This bill protects healthcare providers and individuals from civil and criminal liability when they distribute or use Naloxone and other opioid reversal drugs even after their labeled expiration dates have passed. It allows people acting in good faith to administer these medications to someone believed to be having an opioid overdose without fear of legal consequences, except in cases of gross negligence or intentional misconduct. Healthcare professionals are also shielded from disciplinary action by licensing boards for actions covered under this immunity, though federally certified facilities must still follow federal rules regarding expired medications. The law defines "shelf-life end date" based on federal labeling requirements and takes effect upon the governor's signature.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2026
Committee Review
Apr 2026
House Passage
Apr 2026
Senate Passage
May 2026
Signed into Law
May 2026
Introduced Feb 27, 2026
Signed May 15, 2026
Maddy AI version diff · 3 comparisons
What changed between versions
HB907 Original
→
HB907 Act
·
4 edits
MODERATE
The bill was finalized and enrolled for signature, converting the original draft into official law. The substantive policy content regarding Naloxone immunity remains unchanged, but the text was reorganized to match the standard format of an enrolled act, including the addition of signatures from the Speaker, Senate President, and Governor.
Scope change
The scope of the law itself did not change; the bill covers the same Naloxone distribution rules and immunity provisions as the original draft.
TECHNICAL
Added official enrollment status, Act number (183), and signatures from legislative and executive officials to finalize the bill as law.
Reordered and renumbered sections to align with the enrolled act format, moving the 'shelf-life' definition and federal compliance requirements to follow the immunity clauses.
Removed the legislative digest, abstract, and explanatory notes which are informational and not part of the final legal text.
Changed the header from 'HLS 26RS-1211 ORIGINAL' to 'ENROLLED' to indicate the document is the final version ready for signing.
Floor votes · Senate May 11, 2026 · House Apr 1, 2026
How they voted
36–0
Passed · 4 other
Total votes 40
May 11, 2026
D
Democratic12
83% Yea
R
Republican28
92% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
20
Key actions
4
Committee
5
May 11, 2026
Upper · Passed
Read by title, passed by a vote of 35 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
upper
Apr 27, 2026
Committee
Read by title and referred to the Legislative Bureau.
upper
Apr 22, 2026
Upper · Passed
Reported favorably.
upper
Apr 1, 2026
Lower · Passed
Read third time by title, roll called on final passage, yeas 96, nays 0. Finally passed, title adopted, ordered to the Senate.
lower
Mar 25, 2026
Lower · Passed
Reported with amendments (10-0).
lower
Mar 9, 2026
Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
lower
Feb 27, 2026
Committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dustin Miller
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 907
Scope: LA
Hi! I can help you understand HB 907. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline